Swiss Medtechs Demand Renewed Negotiation Efforts As Latest EU Talks Falter
Executive Summary
Top level EU talks on continued Swiss access to the EU single market have yet to succeed, but with EU MDR implementation in just a month, the stakes for Swiss medtechs are high.
You may also be interested in...
Swiss Consult On Local IVDR Until July, EU MRA Awaited Still
A medtech MRA with the EU remains outstanding. Meanwhile Swiss medtech regulations continue to be harmonized with those of the EU in readiness for future mutual recognition.
Swiss Health Providers Turn Heat On Federal Council: 12% Loss Of Medtech Products Likely On EU MRA Failure
A consortium of Swiss providers, patient groups and health care trade bodies is imploring the federal council to avert a looming patient care crisis in Switzerland if the EU MRA cannot be agreed.
The Sustainability Stakes Are Rising: ‘We Cannot Recycle Our Way Out Of This’
The journey to Net Zero, described as ‘the defining issue of our time,’ will get harder in the coming decade. Failure to keep up the pressure will result in more long-term health conditions, increasing deaths and higher costs. The UK NHS is a Net Zero exemplar globally, but without a systemic approach, its compliance efforts could stutter.